TrialAntimicrobial agents and chemotherapy2019

Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials.

David R Andes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.